Degim Zelihagül, Unal Nilay, Eşsiz Dinç, Abbasoglu Ufuk
Department of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, 06330-Etiler, Ankara, Turkey.
Life Sci. 2004 Oct 22;75(23):2819-27. doi: 10.1016/j.lfs.2004.05.027.
The aim of the study was to determine the penetration properties of various insulin containing liposome formulations through Caco-2 cell monolayer and to compare the in vitro test results with in vivo tests. The effect of sodium taurocholate as a penetration enhancer when it was added to the liposome formulation was also investigated. In vitro permeation experiments were performed in diffusion cells with the Caco-2 cell monolayer used as the membrane. Permeability values of various insulin containing liposome formulations through Caco-2 cells were determined (log k(insulin-solution) = -2.217 +/- 0.0723 cm.h(-1), log k(insulin-liposome) = -2.141 +/- 0.0625 cm.h(-1), log k(insulin-sodium tauroholate liposome)= -1.952 +/- 0.0623 cm.h(-1)). In vivo tests were performed in mice. Formulations were administered orally and blood glucose levels were determined and penetrations were compared with the Caco-2 cell experiment results. In conclusion, the permeability of insulin was increased across Caco-2 cell monolayer when the liposome sodium taurocholate (NaTC) formulation was used. The oral administration of insulin and NaTC incorporated liposomes significantly decreased blood glucose levels. Furthermore, it was shown that a high in vitro/in vivo correlation was observed using the Caco-2 cell monolayer model.
该研究的目的是确定各种含胰岛素脂质体制剂通过Caco-2细胞单层的渗透特性,并将体外测试结果与体内测试结果进行比较。还研究了添加到脂质体制剂中的牛磺胆酸钠作为渗透促进剂的作用。在以Caco-2细胞单层作为膜的扩散池中进行体外渗透实验。测定了各种含胰岛素脂质体制剂通过Caco-2细胞的渗透率值(log k(胰岛素溶液)=-2.217±0.0723 cm·h⁻¹,log k(胰岛素脂质体)=-2.141±0.0625 cm·h⁻¹,log k(胰岛素牛磺胆酸钠脂质体)=-1.952±0.0623 cm·h⁻¹)。在小鼠体内进行测试。口服给药制剂并测定血糖水平,并将渗透率与Caco-2细胞实验结果进行比较。总之,当使用脂质体牛磺胆酸钠(NaTC)制剂时,胰岛素在Caco-2细胞单层上的渗透率增加。口服含胰岛素和NaTC的脂质体可显著降低血糖水平。此外,结果表明,使用Caco-2细胞单层模型观察到了较高的体外/体内相关性。